Skip to main content
. 2022 Sep 13;10(5):e00547-22. doi: 10.1128/spectrum.00547-22

FIG 7.

FIG 7

Protective effect of WYBQ-4 on systemic infection induced by MRSA USA300 and clinically isolated MRSA strains in mice. (A) Experimental protocol for a mouse systemic infection model. (B to D) Protective effects of WYBQ-4, cefepime, and moxalactam against systemic infection induced by (B) MRSA USA300 and clinical isolates of MRSA strains, (C) SA28, and (D) SA1B2B in mice.